A carregar...
Quinuclidine-Based Carbamates as Potential CNS Active Compounds
The treatment of central nervous system (CNS) diseases related to the decrease of neurotransmitter acetylcholine in neurons is based on compounds that prevent or disrupt the action of acetylcholinesterase and butyrylcholinesterase. A series of thirteen quinuclidine carbamates were designed using qui...
Na minha lista:
| Publicado no: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003920/ https://ncbi.nlm.nih.gov/pubmed/33804719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030420 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|